About FRE
Firebrick Pharma Limited (FRE) is developing and commercialising novel formulations and uses of povidone iodine (PVP-I). The Company has developed and manufactured Nasodine Nasal Spray (0.5% PVP-I), which so far has been introduced into the United States, Singapore, and Fiji & South Pacific. The Company is pursuing approval in other markets, including the Philippines.
Find out what a historical investment in Firebrick Pharma would be worth today using our FRE stock calculator.
Market Capitalisation
$8M
Price-earnings ratio
-2.33
Dividend yield
-
High today
$0.03
Low today
$0.03
Open price
$0.03
52-week high
$0.07
52-week low
$0.02
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in FRE
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in FRE on Stake
- Buy FRE from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
FRE related stocks